pexels-pavel-danilyuk-8442102

CAR-T cell therapy

Empowering Your Immune System to Fight Cancer: CAR-T Therapy at Essen BioTech

At Essen BioTech, we believe in harnessing the body’s natural defenses to fight the most challenging battles against cancer. CAR-T therapy is more than just a cure; it is a revolution in oncology care, offering a beacon of hope where conventional treatments may fail.

CAR-T CELL Therapy

Cancers treated with CAR-T therapy

The transformative potential of CAR-T cell therapy has been widely recognized in the treatment of various blood cancers. At Essen BioTech, we are committed to expanding the use of CAR-T therapy to treat other types of cancer, guided by the latest research and clinical trials.

Acute leukemia (ALL + AML)

Treatment includes all types of blood cancers, including acute myeloid and acute lymphocytic.

Chronic Leukemia (CLL+CML)

We treat all types of chronic blood cancer such as chronic lymphocytic and chronic myeloid.

Non-Hodgkin's lymphoma (NHL)

Treatment includes treatment of all types of blood cancer, including lymphoma.

Multiple myeloma (MM)

T-cell therapy has become one of the most important approved treatments for multiple myeloma.

What is CAR T CELL therapy?

Understanding CAR-T Cell Therapy
CAR-T stands for chimeric antigen receptor T-cell therapy, a pioneering approach that involves reprogramming a patient’s T cells to attack cancer cells. Our innovative treatment is designed to deliver targeted, personalized treatment for specific types of cancer by leveraging the inherent strength of a patient’s immune system.

How does CAR-T therapy work?
The CAR-T therapy journey begins with extracting T cells from a patient’s blood. These cells are then genetically modified in our state-of-the-art labs, and endowed with synthetic receptors known as chimeric antigen receptors (CARs). These receptors enable the T cells to recognize and bind to antigens on the surface of cancer cells, destroying them once they are reintroduced into the patient’s body.

Cancers treated with CAR-T therapy
The transformative potential of CAR-T cell therapy has been widely recognized in the treatment of various blood cancers, including:

Acute lymphoblastic leukemia (ALL)
Non-Hodgkin lymphoma (NHL)
Multiple myeloma (MM)
Chronic lymphocytic leukemia (CLL)

At Essen BioTech, we are committed to expanding the use of CAR-T therapy to treat other types of cancer, guided by the latest research and clinical trials.

The Essen BioTech CAR-T treatment process
Collecting T cells
Your journey begins with a simple procedure similar to donating blood, where we collect your T cells according to the highest safety standards.

Genetic modification and expansion
In our specialized laboratories, your T cells are transformed with CARs and multiplied until they number in the millions, ready to fight cancer cells.

Infusion and monitoring
The new CAR-T cells are infused into your body, where they seek out and destroy cancer cells. Our team provides ongoing monitoring to manage any side effects and ensure the best possible outcomes.

The Essen Biotech Advantage
Choosing Essen BioTech for your CAR-T therapy means choosing a center of excellence that is as committed to your health as you are. We offer:

Compassionate care tailored to your unique needs
A multidisciplinary team of leading oncologists, scientists, and care professionals
Advanced facilities that adhere to strict quality and safety protocols
Continuous support throughout your treatment journey

The fight against cancer is a personal journey, and at Essen BioTech, we walk alongside you. CAR-T therapy is a testament to our commitment to innovation, excellence, and most importantly, to you and your loved ones. It’s more than just a medicine. It’s the promise of a brighter, healthier future.

Are you ready to explore how CAR-T cell therapy can be part of your cancer treatment plan? Contact Essen BioTech today to schedule a consultation and take the first step toward empowerment and healing.

Cancer can often seem like an overwhelming, insurmountable challenge. But with innovations like CAR-T therapy, hope isn’t just on the horizon; it’s here. At Essen BioTech, we’re committed to turning that hope into a cure, for every single patient.

Promise of hope

Take the first step in your treatment journey. Connect with our dedicated CAR-T therapy team and discover a world of personalized, compassionate care.

Our amazing numbers speak for themselves!

We have served over 4,000 patients worldwide and are proud to have the world’s best response cases with the best services and great results.

5000+

Patient treated

15+

Years of experience

45

Treatment under development

Address

ESSEN BIOTECH L.L.C. 254 Chapman Rd, Ste 208 #15400 Newark, Delaware 19702, USA Entity ID: 2669872

Call Us

+12077706670

Contact us via email

Support@essen-biotech.com

Subscribe to our newsletter

Get the latest in gene and cell therapy

ESSEN BIOTECH L.L.C. is a registered Biotechnology organization under the Delaware State Division of Corporations, with File Number 2669872. Please note that ESSEN BIOTECH does not have any laboratories outside of the United States of America but conducts clinical trials internationally. ESSEN BIOTECH L.L.C. will never contact you asking for any personal information. To view all available clinical trials, visit ClinicalTrials.gov. You can verify our official registration by visiting the Delaware Department of State: Division of Corporations at the following link: Delaware Entity Search.

X